Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pathologic Complete Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00202839
What this trial is testing

Peg-Intron/Ribavirin in G 1 HCV for Non-Extended Versus 24 Week Extended Treatment After 24 Weeks (Study P04144)(COMPLETED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 160
Not applicableStudy completedNCT04271657
What this trial is testing

RadioPathomics Artificial Intelligence Model to Predict nCRT Response in Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 100
Not applicableStudy completedNCT03697928
What this trial is testing

Markers of Carnitine Acetyltransferase (CrAT) Protein Activity and Carnitine Availability

Who this might be right for
Metabolism and Nutrition DisorderMetabolic Disturbance
Maastricht University 13
Testing effectiveness (Phase 2)UnknownNCT05763992
What this trial is testing

Targeting Triple Negative BREAst Cancer Metabolism With a Combination of Chemoimmunotherapy and a FASTing-like Approach in the Preoperative Setting: the BREAKFAST 2 Trial

Who this might be right for
Breast CancerTriple Negative Breast CancerDietary Exposure+1 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 145
Not applicableStudy completedNCT02948764
What this trial is testing

Diagnosis of Pathological Complete Response by Vacuum-assisted Biopsy After Neoadjuvant Chemotherapy in Breast Cancer

Who this might be right for
Breast Neoplasms
Heidelberg University 452
Testing effectiveness (Phase 2)Looking for participantsNCT07353723
What this trial is testing

Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer

Who this might be right for
Head & Neck Cancer
Tang-Du Hospital 10
Not applicableStudy completedNCT05005169
What this trial is testing

CCA of SGB PCR Versus SGB Culture at 35-38 SA in the Optimization of Intrapartum Antibiotic Prophylaxis

Who this might be right for
Streptococcus Agalactiae
Nantes University Hospital 3,321
Not applicableLooking for participantsNCT06744465
What this trial is testing

NearWave Optical Molecular Monitoring

Who this might be right for
Breast CancerHER2-positive Breast CancerTNBC - Triple-Negative Breast Cancer+2 more
Indiana University 15
Post-approval studies (Phase 4)Looking for participantsNCT07268313
What this trial is testing

Complete Remission After Treatment With Biologics for Nasal Polyps

Who this might be right for
Nasal Polyps
Rigshospitalet, Denmark 66
Not applicableUnknownNCT01863862
What this trial is testing

Organ Preservation in Elderly Patients With Rectal Cancer

Who this might be right for
Rectal Cancer
Maria Sklodowska-Curie National Research Institute of Oncology 90
Not applicableStudy completedNCT02800317
What this trial is testing

RISAS Procedure in Node Positive Breast Cancer Following NAC

Who this might be right for
Breast NeoplasmNeoadjuvant TherapyAxillary Lymph Nodes+1 more
Erasmus Medical Center 248
Not applicableLooking for participantsNCT06281210
What this trial is testing

Vabb After Neoadjuvant Therapy to Avoid Surgery-pCR to Avoid Breast Surgery

Who this might be right for
Breast CancerTriple Negative Breast CancerHER2-positive Breast Cancer+1 more
European Institute of Oncology 77
Large-scale testing (Phase 3)Study completedNCT01197040
What this trial is testing

Evaluation of Low Dose Corticosteroids Efficiency, Associated With Myfortic ® in the Treatment of Nephrotic Syndrome

Who this might be right for
Nephrotic Syndrome
Assistance Publique - Hôpitaux de Paris 117
Testing effectiveness (Phase 2)Study completedNCT02001818
What this trial is testing

Pegylated Interferon Alfa-2b and Nilotinib for Augmentation of Complete Molecular Response in Chronic Myeloid Leukaemia

Who this might be right for
Chronic Myeloid Leukaemia
Australasian Leukaemia and Lymphoma Group 60
Not applicableLooking for participantsNCT05000697
What this trial is testing

Chemoradiation and Consolidation Chemotherapy With or Without Oxaliplatin for Distal Rectal Cancer and Watch and Wait

Who this might be right for
Rectal CancerConsolidation
Hospital Alemão Oswaldo Cruz 216
Not applicableNot Yet RecruitingNCT04225858
What this trial is testing

Avoiding Sentinel Lymph Node Biopsy in Breast Cancer Patients After Neoadjuvant Chemotherapy

Who this might be right for
Breast CancerTriple Negative Breast CancerHER2-positive Breast Cancer+1 more
The Netherlands Cancer Institute 340
Not applicableStudy completedNCT02743910
What this trial is testing

Monitoring Plasma Tumor DNA in Early-Stage Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 228
Not applicableStudy completedNCT03981705
What this trial is testing

Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer

Who this might be right for
TN ER-/PR-/HER2- Breast CancerTriple Negative Breast CancerHER2-positive Breast Cancer+1 more
Masonic Cancer Center, University of Minnesota 8
Testing effectiveness (Phase 2)UnknownNCT03638648
What this trial is testing

Recurrence Score-guiding Chemotherapy in Non-pCR HR Positive HER2 Negative Breast Cancer After Neoadjuvant Therapy

Who this might be right for
Breast Cancer
Zhejiang Cancer Hospital 80
Not applicableStudy completedNCT04939103
What this trial is testing

TRUS-FNA For The Prediction Of pCR After Neoadjuvant Treatment In Rectal Cancer

Who this might be right for
EUS-FNARectal CancerPathological Complete Remission
Sixth Affiliated Hospital, Sun Yat-sen University 63
Next Page